Christopher S. Coyle

Portsmouth, ENG, GB 
Portsmouth, ENG, GB 

Overview

Christopher Coyle practices practicing medicine in Portsmouth, United Kingdom.

His clinical expertise encompasses Gestational Trophoblastic Disease, Hydatidiform Mole, Cerebral Hypoxia, and Agranulocytosis.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Portsmouth, ENG, United Kingdom
Other Locations
Fulham Palace Road, London, ENG W68RF, United Kingdom
Aberdeen, SCT, United Kingdom
Edinburgh, SCT EH114BN, United Kingdom
Bristol, ENG BS105NB, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Capecitabine
Study Phase: Phase 3
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

13 Total Publications

Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study.
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study.
Journal: BMJ medicine
Published: July 11, 2024

Frequently Asked Questions about Christopher S. Coyle

Is Christopher S. Coyle a top-rated expert for Gestational Trophoblastic Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Christopher S. Coyle is classified as an Experienced expert for Gestational Trophoblastic Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christopher S. Coyle participate in research or clinical trials?

Yes. Christopher S. Coyle has published 13 articles and abstracts on conditions like Gestational Trophoblastic Disease. You can view a list of Christopher S. Coyle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Coyle's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile